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Molecular psychiatry of zebraﬁsh
AM Stewart1,2,8, JFP Ullmann2,3,8, WHJ Norton2,4,8, CH Brennan5, MO Parker5, R Gerlai6 and AV Kalueff1,2,7
Due to their well-characterized neural development and high genetic homology to mammals, zebraﬁsh (Danio rerio) have emerged
as a powerful model organism in the ﬁeld of biological psychiatry. Here, we discuss the molecular psychiatry of zebraﬁsh, and its
implications for translational neuroscience research and modeling central nervous system (CNS) disorders. In particular, we outline
recent genetic and technological developments allowing for in vivo examinations, high-throughput screening and whole-brain
analyses in larval and adult zebraﬁsh. We also summarize the application of these molecular techniques to the understanding of
neuropsychiatric disease, outlining the potential of zebraﬁsh for modeling complex brain disorders, including attention-deﬁcit/
hyperactivity disorder (ADHD), aggression, post-traumatic stress and substance abuse. Critically evaluating the advantages and
limitations of larval and adult ﬁsh tests, we suggest that zebraﬁsh models become a rapidly emerging new ﬁeld in modern
biological psychiatry research.
Molecular Psychiatry (2014) 00, 000–000. doi:10.1038/mp.2014.128
INTRODUCTION
Psychiatric disorders affect many brain and behavioral processes,
including thoughts, feeling, sociability and mood. These complex
human diseases also cause a signiﬁcant burden to society,
especially as the available drug therapies have not sufﬁciently
progressed.1,2 The etiology of psychiatric disorders is multifaceted,
and involves the interaction of multiple genetic and environ-
mental factors.
Genetic mutations trigger psychiatric disorders by altering gene
expression and disrupting normal physiological functions of the
brain. Mutations linked to psychiatric disorders are often found in
genes expressed during embryogenesis, and affect early brain
development, cell division, migration, differentiation or survival, as
well as axon path ﬁnding, dendritic architecture and wiring of
neural circuits. For example, Rett syndrome is caused by mutations
in the X-linked MECP2 gene, encoding methyl CpG binding
protein-2 that binds to methylated DNA and controls gene
expression.3 While MECP2 is particularly critical during brain
development, its mutations are also associated with other ‘early-
onset’ developmental brain disorders, such as X-linked mental
retardation and autism3 (also see the substantial contribution of
mutations in genes with higher expression in early fetal life to
schizophrenia4). Environmental factors also have an important role
in psychiatric disorders, leading to well-established gene x
environment (G x E) interactions.5
The notion that psychiatric disorders have fundamental under-
lying molecular mechanisms is critical for understanding complex
brain illnesses, such as anxiety, depression, schizophrenia or
addiction. The promise of such an approach is that once these
mechanisms are identiﬁed and understood, the brain disorder can
be treated, reversed or prevented.6,7
Clearly ‘mainstream’ today, molecular psychiatry had a long
journey before being accepted as a new, dynamic ﬁeld of trans-
lational neuroscience.7 Utilizing various in vivo tests and applying
a wide range of model organisms (Figure 1) is critical for uncover-
ing novel mechanisms of brain disorders.8 Zebraﬁsh (Danio rerio)
have long been underrepresented in experimental biological
psychiatry, and only recently emerged as a model organism in this
ﬁeld.9–11 It is therefore timely to discuss the molecular psychiatry
of zebraﬁsh and its implications for clinical as well as translational
neuroscience research.
THE UTILITY OF ZEBRAFISH FOR TRANSLATIONAL
NEUROSCIENCE
Understanding ‘zebraﬁsh psychiatry’
While zebraﬁsh represent a powerful model for developmental
neuroscience (Figure 1), a combination of well-characterized
neural development and several cutting-edge genetic tools also
makes them an ideal species to study complex psychiatric
disorders. Although similar manipulations are often available in
other vertebrates (for example, mice), the ease of generating large
numbers of ﬁsh, their external fertilization and transparent
embryonic/larval stages are particularly useful, also facilitating
high-throughput screening and central nervous system (CNS)
imaging.10,11 Zebraﬁsh also have an excellent potential to link
genes to CNS disorders, because the nucleotide sequence of
zebraﬁsh genes is homologous (usually exceeding 70%) to the
corresponding human genes, and their function in these distantly
related species is often similar.12 As zebraﬁsh genes can be
mutated with high efﬁciency, the strains (lines) carrying interest-
ing mutations may be detected using phenotype screens, and
the mutated genes can be efﬁciently identiﬁed genetically (see
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Figure 1. A brief summary of zebraﬁsh experimental models in neuroscience research. (a) The evolving nature of zebraﬁsh models in the last
50 years, initially used mainly for basic genetic and neurodevelopmental studies, but more recently applied to developing in vivo models for
complex brain disorders, such as autism, depression and psychoses, is shown. Inset: selected zebraﬁsh strains useful in biological psychiatry
research (top to bottom: adult wild-type zebraﬁsh, casper, spiegeldanio and nacre mutants); photos courtesy of the Kalueff (ZENEREI Institute,
USA), the Norton (University of Leicester, UK), the Parichy (University of Washington, USA) laboratories and Carolina Biological Supply
Company (Burlington, USA). (b) Two research strategies which can both be applied to zebraﬁsh models are illustrated. As a vertebrate species
amenable to in vivo analyses and with high genetic/physiological homology to humans, zebraﬁsh are ideal for ‘intensive’, mechanistically
driven neuroscience research into conserved, core molecular pathways or neural circuits (photo). Due to their small size, ease of maintenance
and short generation time, zebraﬁsh also represent an excellent model for ‘extensive’ biomedical research, including low-cost high-throughput
screening for small molecules or genetic mutations. Both strategies can lead to the development of novel therapies for major psychiatric
disorders. Photo: visualizing zebraﬁsh signaling as an example of intensive, pathway-oriented mechanistic research (the left image shows
expression patterns of genetically encoded calcium indicator (GECI); zebraﬁsh at 5 dpf show pan-neuronal expression of HuC:Gal4; UAS:GCaMP5,
a zoomed-in image on the right shows a single-cell resolution: note that some cells are activated, as indicated by the increased ﬂuorescence;
scale bar 100 μm). (c) The beneﬁts of including inexpensive zebraﬁsh models into preclinical screening batteries are illustrated. A substantial
ﬁscal saving (shown as $) can be achieved by narrowing screening to potentially active compounds using ﬁsh (rather than mice) as the ﬁrst
vertebrate model organism in the screening pipeline. In addition, the risks of missing promising ‘hits’ are lower because the subsequent
screening in mammals will be ‘conﬁrmatory’, and based on more valid data generated from zebraﬁsh (rather than invertebrate or in vitro) tests.
(d) Major neurotransmitter systems in the adult zebraﬁsh brain are summarized: ACh—acetylcholine (dark blue), NA—noradrenergic (purple),
DA—dopamine (green), HA—histamine (orange), 5-HT—serotonin (red); GABA—γ-aminobutyric acid (pink) and Glu—glutamate (light blue).
The highlighted brain regions include olfactory bulb (OB), dorsal pallium (Dp), ventral pallium (Vp), habenula (Ha), optic nerve (ON), facial lobe
(LVII) and vagal lobe (LX). Highlighted areas have been overlaid over a minimum deformation model of the adult zebraﬁsh brain.
Molecular psychiatryQ8 of zebraﬁsh
AM Stewart et al
2
Molecular Psychiatry (2014), 1 – 16 © 2014 Macmillan Publishers Limited
further). Once genes involved in particular functions are identiﬁed
using such ‘forward genetic’ strategy, their biological role(s) may
be thoroughly investigated using ‘reverse genetic’ methods,
speciﬁcally developed for zebraﬁsh (for example, the TALEN
(‘transcription activator-like effector nuclease’) system,13 allowing
targeted mutation of pre-selected sequences). Thus, to the extent
that a psychiatric disease can be modeled in any animal by the
generation of a genetic mutant or by pharmacological manipula-
tion, zebraﬁsh present a useful, cost-effective and uniquely
tractable system.
While aberrant neurotransmission is one of the main causes of
psychiatric disorders,6,7 vertebrate neurochemistry is generally
highly conserved.14–17 Zebraﬁsh possess all primary neuromedia-
tor systems, including transmitters, receptors, transporters and the
enzymes required for synthesis and metabolism of these
mediators.10,11 The spatial and temporal distribution of these
systems has been well characterized in both larval and adult
zebraﬁsh for glutamate, γ-aminobutyric acid (GABA), acetylcholine
and the aminergic neurotransmitters dopamine (DA), noradrena-
line (NA), serotonin (5-hydroxytryptamine, 5-HT) and histamine
(HA, Figure 2b)—key mediators implicated in multiple psychiatric
diseases.
Major neurotransmitter systems in zebraﬁsh
Glutamate is the primary excitatory CNS neurotransmitter involved
in schizophrenia, post-traumatic stress disorder (PTSD) and
epilepsy. Glutamate signaling is visualized using in situ hybridiza-
tion for vesicular glutamate transporters (VGLUT1 and VGLUT2),18
and glutamate metabotropic and ionotropic receptors, including
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Figure 1. Continued.
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Figure 2. Neurobehavioral phenotypes in zebraﬁsh relevant to modeling a diverse group of psychiatric disorders (also see Table 1). Axis represents
ﬁve major phenotypic domains of brain disorders, and includes motor activity, cognition, affect/emotionality, reward and aggression. A dashed-line
pentagon represents ‘normal’ healthy phenotype for each respective axis/domains. (a) Typical zebraﬁsh responses relevant to ADHD (modiﬁed from
Lange et al.125,126) are shown. The bar diagram shows total distance swum in 5min for control larvae and lphn3.1 morphants with and without
methylphenidate (MPH) treatment. The right panel shows representative locomotion traces (recorded from the top view camera) in 6-dpf control and
lphn3.1 morphant zebraﬁsh (green color indicates swimming with normal speed, red color indicates bursts of ‘impulsive’ swimming with high
acceleration). (b) Zebraﬁsh mirror-induced aggression (MIA) responses in the mirror exposure test, and typical patterns of zebraﬁsh aggressive
confrontations (modiﬁed from Norton et al.139) are illustrated. Note that MIA is particularly simple to record and quantify,161 making it also suitable for
high-throughput screening (MIA images in the middle: courtesy of the Robison laboratory,161 University of Idaho, USA). (c) Zebraﬁsh stress- and PTSD-
related aversive behaviors, including neophobia (e.g., acute 5-min exposure to the unfamiliar blue marble in the novel object test) and predator
avoidance (acute 5-min exposure to a predator ﬁsh) are illustrated. Note that zebraﬁsh avoid a blue marble at the bottom of the tank (swim traces in
the open-ﬁeld test recorded by Noldus Ethovision XT8 from the top view), as well as display robust aversion of a live predator (e.g., Leaf ﬁsh), clearly
spending more time in the opposite side of the tank. (d) Zebraﬁsh reward-related addiction behaviors (in the conditioned place preference model,
CPP) and molecular alterations in zebraﬁsh brain following exposure to a substance of abuse are demonstrated. In the CPP, ﬁsh are initially tested for
their preference for both sides of the apparatus, each of which contains a discriminative stimulus (i.e., spots vs no spots). They are then conditioned
with drug to the least-preferred side over a number of sessions. Finally, their preference is assessed again in a probe trial, where the rewarding value
of the drug can be ascertained by calculating the change in preference for the least-preferred side following conditioning (in addition to water
immersion, also note the use of i.p. drug injections in some zebraﬁsh CPP studies184,190). The bottom right bar diagram also shows a classic dose–
response curve for nicotine in adult ﬁsh (also note that mutant heterozygous for a non-sense mutation for the acetlycholinesterase gene (achesb55/+)
do not show place preference for 6 μM nicotine; Brock et al., unpublished observations). Top right bar diagram shows ﬁsh that display persistent
compulsive drug seeking (i.e., drug seeking despite adverse consequences/punishment) following chronic exposure to ethanol or nicotine, also
demonstrating long-lasting drug-speciﬁc and conserved changes in gene expression (brain genes’microarray, inset).197 (e) The reduction in zebraﬁsh
social behavior (e.g., shorter distance between a test ﬁsh and moving shoaling images delivered on a computer screen; inset) is shown. This reduction
in shoaling response is abolished by acute administration of a high concentration of alcohol, which was inactive in ﬁsh chronically pre-treated with
alcohol. Withdrawal from alcohol chronic exposure also abolishes the shoaling response. Note that alcohol-induced behavioral changes in zebraﬁsh
are closely paralleled by alterations in DA levels quantiﬁed from whole brain samples using HPLC (modiﬁed from 203,230).
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three subtypes N-methyl-D-aspartate, AMPA (α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptor) and kainate. VGLUT2
is found in zebraﬁsh embryos beginning at 20–24 h post
fertilization (hpf) in Rohon Beard neurons and in the mediodorsal
domain of the zebraﬁsh spinal cord.19 As the ﬁsh develops, there is
an increase in existing areas of expression, as well as the formation
of new domains throughout the spinal cord. By 4–5 days post
fertilization (dpf), VGLUT1 and VGLUT2 are distributed throughout
the majority of midbrain, hindbrain and spinal cord.19 Examination
of the expression patterns of glutamate metabotropic receptors in
zebraﬁsh reveals a similar pattern to that seen in rodents, with
glutamate metabotropic receptor expression in larval and adult
zebraﬁsh found in the olfactory bulb, optic tectum, hypothalamus,
cerebellum and retina.20 Zebraﬁsh also possess high-afﬁnity
excitatory amino-acid transporters (EAATs), which regulate gluta-
mate levels and prevent excitotoxicity. Four of the ﬁve EAAT-
related genes are found in the zebraﬁsh genome, including three
EAAT1 paralogs, EAAT2, EAAT3 and two EAAT5 sequences.21
GABA is the primary inhibitory neurotransmitter in the adult
CNS, modulating neuronal excitability and also exerting its action
during development. Altered GABA and glutamic acid decarbox-
ylase (the enzyme producing GABA from glutamate) are seen in
many CNS disorders, including attention-deﬁcit/hyperactivity
disorder (ADHD), bipolar disorder and major depression.22–24
Expression patterns of GABA are usually investigated by direct
immunostaining for GABA or the two glutamic acid decarboxylase
isoforms (GAD65 and GAD6725), as well as by visualizing the
ionotropic and metabotropic GABAA/C and GABAB receptors.
26 In
the embryonic zebraﬁsh, GABA-immunoreactive (ir) cells can be
detected very early during development. By 16 hfp, GABA-ir cells
are found in the telencephalic nucleus, the nucleus of the tract of
the postoptic commissure, the nucleus of the medial longitudinal
fascicle and throughout the hindbrain and spinal cord.27 At 24 hpf,
existing ir-cell clusters increase in cell numbers, and new clusters
are located in the dorsomedial nucleus of the posterior
commissure and the primordium of the hypothalamus. As
the zebraﬁsh develops, three identiﬁable GABAergic axonal
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projections include the supraoptic tract, the tract of the postoptic
commissure and the medial longitudinal fascicle. By 3 dpf, the
distribution of GABA-ergic neurons in the zebraﬁsh brain is very
similar to its mammalian counterparts at a corresponding deve-
lopmental stage.28 GABA-ir cells are widely distributed, locating in
the olfactory bulb, subpallium, posterior preoptic area, the dience-
phalic basal plate, the central optic tectum, torus semicircularis,
ventral mesencephalic tegmentum, valvula of the cerebellum and
medulla oblongata.19,28 In adult zebraﬁsh, GABA is broadly
distributed. GABA-ergic expression in the telencephalon is very
similar to embryonic zebraﬁsh, with GABA-ir cells in the internal
cellular layer of the olfactory bulb29 and all regions of the sub-
pallium, as well as the preoptic, pretectal, ventral, thalamic, hypo-
thalamic, preglomerular and posterior tubercular nuclei, cerebellar
corpus, valvus and vestibulolateral lobe.25,26
DA and NA are the primary catecholamine neurotransmitters in
zebraﬁsh. DA has a key role in modulating learning, memory,
motor control, food intake and motivation. Deﬁcits of DA neuro-
transmission have been implicated in bipolar disorder, schizo-
phrenia, ADHD and drug addiction. NA-ergic neurons serve an
important function in the autonomic nervous system, but also
modulate attention, arousal, reward, depression and schizophre-
nia. In zebraﬁsh, the catecholaminergic signaling pathways have
been characterized by visualizing the temporal and spatial
expression of tyrosine hydroxylase (TH)30,31 or the th transcript32
in all catecholaminergic neurons, the DA transporter (dat) for DA
neurons and DA beta hydroxylase (dbh) for NA neurons,33,34 and
the three zebraﬁsh DA receptors D1, D2 and D3.35,36 Zebraﬁsh DA-
ergic neurons are ﬁrst formed in the telencephalon (olfactory bulb
and subpallium) and diencephalon (preoptic area, pretectum,
ventral thalamus, posterior tuberculum and hypothalamus) with
projections that terminate locally.30,33 In adult zebraﬁsh, th1 and
th2 are differentially expressed, with th1 expressed in the tele-
ncephalon, ventral thalamus and pretectum, th2 more broadly
distributed in the hypothalamus, and both genes strongly
expressed in the posterior tuberculum and preoptic region.32
There are some notable differences between zebraﬁsh and
mammals: for example, zebraﬁsh lack DA-ergic cell groups in
the mesencephalon14,33 and ventral midbrain,37 but possess an
additional pretectal group.18 The zebraﬁsh NA system is very
similar to mammals, with NA cell groups located in the locus
coeruleus, medulla oblongata and area postrema (AP).38,39
Zebraﬁsh NA neurons can already be identiﬁed by 16 hpf, with
few changes between larval and adult ﬁsh.40 Projections from NA
neurons are also conserved between zebraﬁsh and mammals,37
with neurons in the locus coeruleus projecting to telencephalon,
diencephalon and mesencephalon, in the medulla projecting to
hindbrain and spinal cord, and in the AP projecting to the same
areas as the locus coeruleus.40
HA also has a key role in regulating diverse brain functions (for
example, higher cognitive functions, circadian rhythms and
locomotor activity) and modulating other aminergic systems.
The zebraﬁsh HA-ergic system is very similar to other vertebrates,
with L-histidine decarboxylase and three of the four HA receptors
(H1, H2 and H3) found in the brain.41 The ﬁrst HA-ir neurons
detected in zebraﬁsh embryos are located in the ventral
hypothalamus at ~ 85 hpf, and by 90 hpf the ﬁrst ir-ﬁbers can
be detected in the dorsal telencephalon.42 In adult zebraﬁsh, HA-ir
neurons are found in the ventrocaudal region of the hypothala-
mus surrounding the posterior recess16 and innervate every major
region in the brain (except the cerebellum).14
5-HT mediates excitatory and inhibitory neurotransmission,
serving a critical role in aggression, anxiety, cognition, learning,
memory, mood and sleep. Perturbation of 5-HT levels during
development have been implicated in abnormal psychiatric
behaviors, such as anxiety spectrum disorders, schizophrenia
and depression.43 Zebraﬁsh express four 5-HT receptors (htr1aa,
htr1ab, htr1bd and htr2c),44,45 the spatial expression of which in
the brain is primarily visualized by immuno-histochemistry and
in situ hybridization.46 More recently, transgenic strains expressing
enhanced green ﬂuorescent protein under control of the zebraﬁsh
raphe-speciﬁc gene pet1 have also been developed.47 5-HT
neurons are expressed in the spinal cord of embryonic zebraﬁsh
by 1 dpf, with additional clusters distributed throughout the brain
(including the telencephalon and the hindbrain) by 5 dpf.30,48 In
adult zebraﬁsh, 5-HT neurons are primarily located in the raphe
nucleus with ascending projections terminating in telencephalon,
diencephalon, tegmentum, hindbrain and spinal cord.47 Addi-
tional groups of anatomically distinct clusters of 5-HT-ir cells are
also found in the pineal, pretectal area, posterior tuberculum and
hypothalamus, reticular formation, AP and spinal cord.14,47,49 5-HT
neurons have also been identiﬁed by the expression of other
markers, such as three tryptophan hydroxylase genes (tph1a,
tph1b and tph2),50,51 two 5-HT transporters genes (serta and
sertb)44,52 and two vesicular monoamine transporter genes (vmat1
and vmat2).53 Examination of the transporter genes permits more
speciﬁc analysis of temporal and spatial expression pattern of
5-HT, since it can be unique, with serta expressed in the pineal,
pretectal area and raphe, and sertb in the retina, posterior
tuberculum/hypothalamus and AP.54
Acetylcholine has a fundamental role in CNS functions (for
example, sleep, learning/memory and attention) and dysfunctions
(for example, schizophrenia, ADHD and depression). The zebraﬁsh
cholinergic system is generally similar to other vertebrates, with
both muscarinic55 and the full set of nicotinic receptors.56,57 The
distribution of cholinergic neurons in the zebraﬁsh brain has been
primarily described by mapping the enzymes choline acetyltrans-
ferase and acetylcholinesterase (AChE). Cholinergic-ir neurons ﬁrst
appear immediately after hatching in the zebraﬁsh embryo optic
tectum. By 60 hpf, additional cells are seen in the preoptic area
and tegmentum, and by the completion of the embryonic stage,
additional reactivity is seen in the isthmic region and medulla
oblongata.58 Adult zebraﬁsh display widespread distribution of
both choline acetyltransferase and AChE. AChE-ir neurons are
found in the preoptic region, periventricular layer of the optic
tectum, rostral tegmental, oculomotor, trochlear nuclei of the
mesencephalic tegmentum, isthmic region, octaval nuclei and
motor nuclei of the cranial nerves.59 In contrast, choline acetyl-
transferase-ir neurons are located in the pretectum and the
tectum, except the marginal layer, the mesencephalic tegmentum,
isthmic region, in Purkinje and granule cells in the cerebellum, and
throughout the medulla.
Finally, it is important to consider the ﬁsh-speciﬁc genome
duplication that occurred around 450 million years ago.60 In
zebraﬁsh, this duplication resulted in expressing more neuro-
transmitter receptors than other species. For example, zebraﬁsh
have an estimated 122 G-protein coupled receptors for biogenic
amines (such as 5-HT, NA, DA, HA, adrenaline and trace amines),
compared with 57 in mouse and 44 in humans.61 Importantly, not
all zebraﬁsh receptor paralogs have been identiﬁed and char-
acterized. For example, to date only three 5-HT receptors have
been cloned, despite the existence of seven distinct 5-HT receptor
families in other animals.44 Furthermore, the functional and
pharmacological properties of zebraﬁsh receptors have not been
well studied,62 making it more difﬁcult to translate information
across species. One reasonably well-characterized group is the
alpha-2 adrenoceptors (adra2). The zebraﬁsh genome contains
ﬁve adra2 receptors, three of which (adra2a, adra2b and adra2c)
are conserved with mammals.63 However, the other two subtypes,
adra2da and adra2d, are zebraﬁsh speciﬁc, whereas mammalian
adra2a-c paralogs are not found in ﬁsh. Strikingly, despite fairly
low sequence homology (~55% overall, rising to ~ 75% in the
trans-membrane domains), human and zebraﬁsh receptors show
similar ligand-binding proﬁles.64 For example, the adra2 agonist
dexmedetomidine acts as a sedative in zebraﬁsh and other
species, an effect that can be inhibited by the adra2-speciﬁc
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antagonist atipamezole.65 Thus, while the function of these
receptors appears to be conserved across species,65 the increased
number of neurotransmitter receptors in zebraﬁsh (vs mammals)
means that their pharmacological and functional properties must
be carefully examined before translating them to other species. In
particular, the above-mentioned sub-functionalization of receptor
subtypes implies that manipulating genes linked to psychiatric
disorders may not recapitulate all symptoms of a disease, and that
some novel drugs characterized in ﬁsh may have different
pharmacological properties in humans (see further).
Visualizing zebraﬁsh CNS signaling pathways
Imaging neural patterns and circuits is a key strategy in bio-
psychiatry research, and zebraﬁsh offer a highly amenable
experimental model for investigating the spatiotemporal distribu-
tion of neurotransmitter systems. In addition to conventional
immunohistochemistry for neurotransmitter proteins or in situ
hybridizations for the transcripts, recent genetic and technological
developments permit in vivo screening, high-throughput analyses
and whole-brain assays in this model organism.
Larval zebraﬁsh are particularly suited for translational models
of psychiatric disease because they are small, undergo external
development, and are transparent (until all major organs, includ-
ing the brain, have fully developed).10,11 This permits neurons in
larval ﬁsh to be easily observed in vivo and then ablated or
manipulated. A wide range of genetic tools, developed or adapted
to zebraﬁsh to transiently alter gene expression and generate
knockout disease models, includes antisense oligonucleotides
(the morpholinos), zinc ﬁnger nucleases,66 TALEN13 and TILLING
(‘targeting induced local lesions in genomes’).67 Similar to
invertebrate models, novel mutants or small molecules can then
be rapidly screened (in the thousands) using a combination of
conventional ﬂuorescent or confocal microscopy with automated
ﬂuidic screening platforms.68,69
Complementing multiple genetic methods, a suite of sophisti-
cated tools also help elucidate the anatomical alterations
associated with novel phenotypic alterations. These techniques
include in vivo monitoring of neural activity, functional analyses of
speciﬁc neurons and tracing of neural circuits. Genetically
encoded calcium indicators (GECIs, such as the GCaMP reporter
constructs) ﬂuoresce when calcium is present, thereby serving as
an indicator for action potential ﬁring.70 By driving expression with
the Gal4/UAS71 or transposon-based Tol2 systems72 GECIs and
optogenetic constructs, such as channelrhodopsin and halorho-
dopsin, can easily be inserted into the zebraﬁsh genome to target
speciﬁc cellular populations and perform functional analyses. With
advanced microscope techniques (for example, light-sheet micro-
scopy), functional imaging of the entire brain of a larval zebraﬁsh
can be performed in o1.5 s,73 a task unattainable in other verte-
brate models. In contrast to rodents, this procedure is also almost
entirely non-invasive, and does not require attaching ﬁber optic
cables. Albeit currently used in zebraﬁsh to address fundamental
questions (for example, sensory processing74 or motor control75),
this optogenetic toolbox can be similarly employed in this
organism to model altered neural activity associated with
psychiatric disease in humans.76
Fluorescent markers (for example, green ﬂuorescent protein)
can also be utilized to resolve the neuronal projections and
formation of neural circuits in larval zebraﬁsh. Using combinatorial
expression of several ﬂuorescent proteins to individually label
neurons and their projections,77 Brainbow technology can be
particularly useful for examining disease phenotypes related to
miswired neural circuits (for example, autism78). Brieﬂy, Brainbow
visualizes synaptic circuits by labeling neurons genetically, using
Cre/lox recombination to create a stochastic choice of expression
between several ﬂuorescent proteins.79–81 Originally developed in
mice, this transgenic technology has been successfully applied to
other model organisms, including zebraﬁsh,77 to map multiple
individual cells within a population and provide a large-scale
dissection of CNS circuitry.80,81 A recent modiﬁcation of Brainbow,
the Zebrabow, has been introduced for in vivo multicolor imaging
in zebraﬁsh.82 Applying several new transgenic strains for
ubiquitous or tissue-speciﬁc multicolor labeling, this approach
maximizes color diversity by optimizing Cre activity, and can be
particularly useful for long-term color-based anatomical and
lineage analyses in a wide variety of zebraﬁsh tissues, including
neurons and glia.82
Furthermore, while calcium and voltage sensors are funda-
mental to functional analyses in the larval zebraﬁsh brain, they do
not speciﬁcally measure neurotransmitter release or concentration
(typically measured by cyclic voltammetry, HPLC or ELISA).
However, more recent speciﬁc markers enable in vivo measuring
of neurotransmitters, based on placing a ﬂuorescent label very
close to the synapse, labeling the synaptic vesicle content or
directly measuring extracellular neurotransmitters. Fluorescent
false neurotransmitters are optical tracers that permit visualization
of neurotransmitter release and uptake at presynaptic terminals.83
Initially developed for the DA-ergic system, ﬂuorescent false
neurotransmitters are ﬂuorescent substrates for targeting vesicular
monoamine transporter 2, carrying monoamine neurotransmitters
to synaptic vesicles. Fluorescent false neurotransmitter has also
recently been extended to be a pH-responsive DAT substrate,
which is able to identify DA cell bodies and dendrites and
measures DAT activity and DA release at individual synapses.84
Several optical sensors have also been developed to measure
excitatory synaptic activity in the brain. The glutamate optical
sensor is a ﬂuorescent indicator made up of the glutamate-
binding domain of the AMPA and a small ﬂuorescent molecule
bound near the glutamate-binding pocket.85 When bound to
glutamate the glutamate optical sensor changes its ﬂuorescence
intensity. Intensity-based glutamate-sensing ﬂuorescent reports
are a single-wavelength glutamate sensor that responds to
glutamate in situ and therefore directly reports excitatory synaptic
release.86 This sensor can be genetically encoded and used in
zebraﬁsh to demonstrate the spatial organization of direction-
sensitive synaptic activity in the optic tectum.86 Finally, ﬂuorescent
indicators for acetylcholine volume transmission have also been
created. Cell-based sensors of neurotransmitters are cultured cells
that co-express M1 muscarinic receptors and the GECI TN-XXL, and
(when implanted into the brain) provide a ﬂuorescent readout of
acetylcholine levels.87
Imaging neurotransmitter systems in the adult zebraﬁsh brain
are signiﬁcantly more difﬁcult due to its increased size and lack of
transparency. While transparent zebraﬁsh strains (for example,
absolute, nacre and casper, Figure 1a) exist,88 the brains are still
relatively opaque making it difﬁcult to image the various photo-
proteins described above. As a result, studies have typically been
limited to sectioning the brain. However, numerous methods may
render a ﬁxed brain transparent and, when imaged with long
working distance objectives, permit the examination of neuro-
transmitters in situ.89–96 These techniques use hydrophobic or
hydrophilic chemical mixtures to remove lipids and reduce light
scattering to visualize endogenous ﬂuorescent markers in
the brain.
Additional zebraﬁsh neuroimaging tools
Several gene transcription factors, such as Pax3 (pair box 3), Fos
and Otp (Orthopedia), represent a useful tool for visualizing CNS
development and function in zebraﬁsh. For example, Pax3 is a
transcription factor that regulates cell proliferation, migration and
neural development. Its gene is not only highly conserved (at the
sequence level) between zebraﬁsh and mammals, but also shows
similar pattern of neural expression during embryogenesis.97–99
Thus, analyses of Pax3 expression in zebraﬁsh can be particularly
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useful for imaging early CNS development,97,98 which is relevant
to modeling many neurodevelopmental disorders.
The homeodomain transcription factor Otp is an important
regulator of neuroendocrine and dopaminergic cells in vertebrate
species.100,101 Otp has two paralogs in zebraﬁsh (otpa and otpb),101
and genetic manipulations suppressing Otp deplete certain dopa-
minergic neurons, enabling a functional dissection of dopaminer-
gic contribution to CNS circuitry in early larval zebraﬁsh.102
Likewise, an early proto-oncogene c-fos serves as a well-
established marker of neuronal activation in various species,
including humans,103 rodents104,105 and zebraﬁsh.106 For example,
c-fos expression analyses of whole-brain zebraﬁsh samples can be
used to assess neuronal activation globally (for example, reﬂecting
CNS excitation during epilepsy106,107 or following anxiogenic/
anxiolytic or hallucinogenic treatments108,109). Region-speciﬁc
analyses of c-fos expression in zebraﬁsh brain offer a more
detailed functional mapping of neural circuits during various
behavioral tests.110 For instance, in the light-dark test, c-fos
neuronal activity mapping implicated several brain regions,
including several telencephalic areas (the teleost homologs of
the mammalian amygdala and striatum), during zebraﬁsh
‘anxiogenic’ light avoidance behavior.110 Characterizing neuronal
activity induced in zebraﬁsh by acute amphetamine, drug-seeking
or the light avoidance behavior, quantitative analyses of c-fos
expression can also be combined with neuronal subtype-speciﬁc
markers at single-cell resolution.111 Showing the recruitment of
the medial and the lateral pallium (structures homologous to the
mammalian amygdala and hippocampus), these data suggest
evolutionarily conserved function of amygdala-like structures in
positive emotions and motivated behavior in zebraﬁsh and
mammals.111 Collectively, this evidence strongly supports the
utility of c-fos and other biomarkers in visualizing normal and
aberrant CNS development and functioning.
Finally, with the increased use of zebraﬁsh in disease genetics
research, a quantitative voxel-based technique may help compare
disease models with wild-type zebraﬁsh. Magnetic resonance
imaging is an inherent 3D tool that facilitates investigations in
morphology, connectivity and function of the brain. Due to its 3D
nature, multiple data sets can be mapped to a standard
coordinate space and registered to produce a model representa-
tive of a population (thus, limiting individual morphological
variance and instead demonstrating the average morphology of
the entire population). Data collected from magnetic resonance
imaging can include mean volumes of individual brain regions,
the stereotaxic locations of individual structures and major ﬁber
bundles, and functional activity. Importantly, magnetic resonance
imaging models can also serve as a canonical space for
registration of other imaging data sets. For example, recent
whole-brain immunostaining and light microscope imaging (for
example, SeeDB or Clarity), optical projection tomography and
microCT can all be registered to the same stereotaxic space,
collectively enabling quantitative analysis of a wide range of
markers in zebraﬁsh brain.
ZEBRAFISH MODELS OF BRAIN DISORDERS
Bridging molecular events with behavior
Many psychiatric disorders are moderately or highly heritable, and
have developmental trajectories.112,113 As behavior is controlled
by activity within neural circuits, a major challenge is to map the
genotype–phenotype relationship to understand how genetic
variations affect neural circuits that control behavior. Various
molecular tools have been effectively used for uncovering brain
mechanisms in zebraﬁsh. For example, in addition to traditional
N-ethyl-N-nitrosourea-induced114 and viral-vector-mediated115
mutagenesis, new sophisticated ‘gene-breaking transposon’
(GBT)116 screens and ‘clustered regularly interspaced short
palindromic repeats’ approaches for generating targeted zebraﬁsh
mutants have been developed.117 Combined with TILLING and
TALEN tools, this makes the process of exploring genotype–
phenotype relationships in zebraﬁsh better targeted and less
labor-intensive. With the establishment of translationally relevant
zebraﬁsh behavioral assays9–11 comes the ability to apply these
molecular techniques to modeling psychiatric diseases. Here, we
discuss how various zebraﬁsh models can be utilized to target
selected psychiatric disorders and their neurodevelopmental
trajectories. ADHD, aggression, post-traumatic stress and drug
abuse (Figure 2) were selected as examples, reﬂecting a wide and
diverse spectrum of psychiatric disorders that can be modeled
using the zebraﬁsh.
Modeling ADHD
Zebraﬁsh have recently been utilized to investigate some aspects
of ADHD (Table 1; Figure 2a), a common psychiatric disorder
affecting ~ 3–5% of children worldwide. ADHD symptoms
(inattention, hyperactivity and impulsivity) persist into adulthood
in ~ 50% of cases, reducing the patients’ quality of life, academic
performance and sociality.118,119 Altered DA, NA, 5-HT and
glutamate neurotransmission in the prefrontal cortex, striatum,
parietal cortex, vermis and the inferior lobes of the cerebellum are
implicated in ADHD.120–123
An interesting example of using larval zebraﬁsh to model this
disorder involves a human gene LATROPHILIN3 (LPHN3), identiﬁed
as candidate ADHD gene by linkage analysis.124 In zebraﬁsh, its
homolog latrophilin3.1 (lphn3.1) has a developmental role, and is
expressed in differentiated neurons throughout the brain up to 6
dpf. The lphn3.1 morphants display increased distance swum at 6
dpf (Figure 2a)125,126—the hyperactivity phenotype also main-
tained during the night, demonstrating a permanent increase in
Table 1. Examples of a diverse group of psychiatric disorders (Figure 2) which can be modeled in zebraﬁsh (see Kalueff et al.135 for a comprehensive
catalog of zebraﬁsh normal and pathological behaviors)
Selected disorders Zebraﬁsh phenotypes References
Attention deﬁcit hyperactivity
disorder (ADHD)
Impulsive swimming with hyperactive locomotion and impulsivity-like bursts
of accelerated swimming, which can be reduced by anti-ADHD drugs (Figure 2a)
125,126,217,218,231
Aggression Social deﬁcits (disrupted shoaling behavior), increased aggressive behaviors
(follows, chases and biting), mirror-induced aggression (MIA) (Figure 2b)
135,139,161
Post-traumatic stress
disorder (PTSD)
Reduced exploration following stress, increased avoidance (e.g., neophobia;
Figure 2c), erratic behavior and freezing, elevated cortisol and brain c-fos
(all highly sensitive to a wide range of anxiolytic and anxiogenic agents),
social deﬁcits (e.g., disrupted shoaling behavior)
144,146,147,232
Substance abuse, addiction
(reward-related behavior)
Robust conditioned preference for commonly abused substances, compulsive
drug seeking (i.e., despite adverse consequences; Figure 2d), withdrawal syndrome,
stimulus-induced relapse following extinction, altered social behavior (Figure 2e)
197,198,201,202,205,233–235
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locomotion compared with control animals. Morphant larvae also
show more bursts of accelerated swimming, indicative of motor
impulsivity. Both hyperactivity and motor impulsivity can be
rescued by the prototypical anti-ADHD drugs methylphenidate
and atomoxetine (Table 1). While acute 1-h treatment with either
drug had no effect on control-injected larvae at the doses used, it
rescued morphant behavior bringing locomotion back to control
levels. The lphn3.1 morphants also display fewer cells in the
posterior tuberculum, a prominent group of DA-ergic neurons in
the ventral diencephalon that control larval locomotion and
project both anteriorly and posteriorly, but mainly to the spinal
cord.101,127 Thus, despite the difﬁculty of fully modeling ADHD in
zebraﬁsh, research in these animals shows an important role for
lphn3.1 in DA-ergic neuron development128 (also see similar data
in mice,129 proving the feasibility of translating ﬁndings from
zebraﬁsh to other species).
Exposure of zebraﬁsh embryos to chemicals during develop-
ment may also provide insights into possible environmental
causes of ADHD. For example, prenatal exposure to perﬂuor-
ooctane sulfonate has been linked to clinical adolescent ADHD,130
and treating zebraﬁsh embryos with this agent during develop-
ment elicits ADHD-like behaviors in 6-day-old larvae (i.e.,
hyperactivity, motor impulsivity and hyper-responsiveness to
startle).131 This phenotype is reminiscent of the behavior of
lphn3.1 larvae and strikingly, these behavioral changes can be
rescued by dexamfetamine, implicating DA signaling in this
phenotype. Zebraﬁsh are also used to study the consequences of
long-term exposure to methylphenidate, displaying elevated DA,
NE and 5-HT in the larval brain, and lasting behavioral changes (for
example, impaired predatory escape and learning).132 Such ease
of conducting embryonic manipulations and behavioral experi-
ments in zebraﬁsh strongly supports their potential for studying
ADHD and related disorders.
Zebraﬁsh models of aggression
Aggression, an adaptive animal behavior to monopolize resources,
is essential for the organism’s ﬁtness and survival. However,
pathological aggression is part of various brain disorders, and
merits further studies in vivo models. Although aggression has
long been studied in ﬁshes, the genetic and neurobiological tools
available in zebraﬁsh make them an ideal species to study
aggression. Zebraﬁsh display aggression as a series of stereotypic
body postures (for example, undulating body movements, short
slaps of the caudal ﬁn and bouts of swimming and biting directed
against an opponent) which can easily be measured in the
laboratory.133 Aggressive incidents follow a highly structured
pattern,134 from extending the ﬁns to circling, chasing and
attempting to bite, further progressing to more frequent chases,
bites and attempts to strike the opponent. The ﬁsh that loses such
as encounter becomes submissive, exhibiting postures that
include ﬂeeing, freezing and retreating.134,135 In laboratory
zebraﬁsh, aggression can be measured by recording the interac-
tion of two ﬁsh in a tank, or the interaction of a single ﬁsh with its
own reﬂection in the mirror exposure test (mirror-induced
aggression, MIA; Figure 2b).133,134
Mounting evidence shows that zebraﬁsh aggression has a
genetic basis, and its moderate heritability suggests that environ-
mental inﬂuences (for example, maternal care, rearing conditions
and environmental complexity) also contribute to this behavior.
For example, aggression/boldness proﬁles in several wild-type
zebraﬁsh strains (TM1, SH and Nadia) show strain differences in
MIA, supporting the genetic basis of aggression in zebraﬁsh.136
A group of 40 genes linked to aggression have been identiﬁed
in ﬁsh, with differences in expression level depending on both
the area of the brain analyzed and the sex.137 HPLC analyses of
adult zebraﬁsh brains following an aggressive interaction reveal
altered DA, 5-HT and their metabolites in the telencephalon,
diencephalon and optic tectum. Other important brain areas
include the preoptic area of the anterior hypothalamus138 and the
periventricular nucleus of the inferior hypothalamus.139 Notably,
similar brain areas have been linked to agonistic behavior in other
vertebrates, highlighting the translatability of zebraﬁsh research in
this ﬁeld. Like in other vertebrates, ﬁsh aggression is controlled by
similar neurotransmitters, peptides and hormones, including DA,
5-HT, HA, 17α-ethinylestradiol and arginine vasopressin/vasotocin.
For example, addition of estrogen to tank water alters zebraﬁsh
aggression, implicating certain pathways and circuits,133,140 as
reduced aggression in dominant male zebraﬁsh correlates with
altered 5-HT, DA, arginine vasopressin levels and the expression of
the somatostatin pathway genes.141
A recently characterized novel aggressive spiegeldanio mutant
zebraﬁsh (spd, Figure 1a)142 harbors a mutation in the fgf receptor
1a gene, which disrupts the ﬁbroblast growth factor signaling in
the brain. Fibroblast growth factors are a large family of secreted
signaling molecules with important roles during development.143
Homozygous spd mutants show unaltered locomotion but increased
aggression, boldness and exploration (Figure 2b), correlated with
elevated breakdown of HA in the brain, and reduced neuro-
transmitter signaling in the hypothalamic periventricular nucleus.
Importantly, pharmacological increase in HA rescues all three
behavioral alterations in spd mutants.139 Although spd zebraﬁsh
are always more aggressive than wild-type siblings, their behavior
differs between the laboratories (for example, similar boldness but
higher aggression in mutants raised in Germany vs France).139
Taken together, these results demonstrate the importance of
environmental inﬂuences on aggression, and that experimental
modulation of selected target genes can strongly affect zebraﬁsh
aggressive phenotypes.
Post-traumatic stress disorder
Severe stress is the main cause of PTSD and other trauma/stress-
related disorders. Zebraﬁsh have recently been proposed as potential
models of PTSD and trauma/stress-related disorders.144,145 The
extensive, complex repertoire of behavioral responses of zebraﬁsh
to a wide variety of stress-evoking stimuli closely parallels that
observed in mammalian models of PTSD (Figure 2c; Table 1).145
For example, various PTSD-relevant phenotypes identiﬁed in
zebraﬁsh include robust anti-predatory responses146,147 and
inhibitory or active avoidance conditioning.148 Paralleling mam-
malian tests, an increasing number of zebraﬁsh paradigms
relevant to PTSD continue to be developed, based on fear
conditioning148–152 and exposure to aggressive conspeciﬁcs,134,138
predators or other acute stressors (Figure 2).153–155 Moreover, the
highly social nature of zebraﬁsh156–158 offers further potential to
examine pathological social phenotypes, representing the serious
adverse clinical effects of PTSD/trauma/stress-related disorder. For
instance, experimentally evoked disorganization in the social
structure of zebraﬁsh groups (shoals)158–161 may represent an
interesting PTSD-related ‘social withdrawal’ phenotype.145
The physiology of zebraﬁsh also supports their suitability for
modeling PTSD and other stress-related CNS disorders.120,121
Zebraﬁsh rapid development enables time- and cost-efﬁcient
modeling of the developmental and ‘temporal’ pathogenetic
aspects of PTSD. Moreover, given the strong involvement of the
neuroendocrine stress axis in PTSD,162 the cortisol-driven neu-
roendocrine axis of zebraﬁsh makes them well suited for studying
glucocorticoid regulation in stress and PTSD.163,164 For example,
zebraﬁsh grs357 mutants, possessing non-functional glucocorticoid
receptors, have recently offered a model of glucocorticoid
resistance to study the developmental effects of glucocorticoid
signaling deﬁcits on stress physiology and related behaviors.165,166
Furthermore, an extensive array of homologs of clinical biomar-
kers of PTSD has also been identiﬁed in zebraﬁsh, including
corticotropin releasing factor,167,168 glucocorticoid receptor,169,170
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adrenocorticotropic hormone,171,172 neuropeptide Y,173,174
catechol O-methyltransferase5,175,176 and monoamine oxidase
A/B.171,177 Finally, the sensitivity of zebraﬁsh sympathetic and
parasympathetic responses (for example, altered heart rate) to
pharmacological manipulation has recently been established,178
offering the potential to study autonomic biomarkers of PTSD-
relevant drug treatments. Overall, zebraﬁsh emerge as a promising
new model to complement traditional rodent models of
PTSD.10,144,145
Addiction, substance abuse
Zebraﬁsh are increasingly utilized as a preclinical model to
investigate molecular mechanisms of substance abuse. Drugs of
abuse typically exert their effects by modulating DA pathways in
the midbrain,179 and the ascending DA systems (VTA-NAc reward
pathway) in zebraﬁsh share functional homology with those of
mammals.180,181 Zebraﬁsh express orthologs for many addiction-
related human genes,182 including the majority of the DA-, 5-HT-
and cholinergic receptor gene families. Zebraﬁsh also display
robust reward responses to translationally relevant doses of common
drugs of abuse, including stimulants (cocaine,183 amphetamine,184
nicotine185 and caffeine; Brock and Brennan, unpublished data),
ethanol,185 opiates (morphine,186 fentanyl) and general anaes-
thetics (tetracaine and ketamine; Brock and Brennan, unpublished
data). As drug-seeking behavior is evolutionarily conserved,
zebraﬁsh represent a powerful in vivo model to assess the
contribution of genetic factors across speciﬁc endophenotypes or
drugs of abuse.
The ﬁrst systematic screens relevant to addiction, examining
mutant alleles affecting catecholaminergic neurons,187 showed
that DA/hypothalamic neuronal development is regulated by
forebrain embryonic zinc ﬁnger-like protein (fezl),188 the mutation
of which in zebraﬁsh reduces opiate (but not food) reward.189
Subsequent studies performed conditioned place preference (CPP,
Figure 2d) screens of N-ethyl-N-nitrosourea-mutagenized F2 adult
ﬁsh for cocaine and amphetamine reward,183 and found a number
of families showing heritable reduced reward sensitivity.184 For
instance, the nad+/− mutant zebraﬁsh show insensitivity to the
rewarding effects of amphetamine.190 Microarray analysis, followed
by qPCR conﬁrmation, identiﬁed multiple genes that were
upregulated/downregulated in the nad mutant, particularly relating
to neurogenesis and brain development. Similar approaches have
been applied to assess drug-induced reward and to identify novel
genes and molecular pathways involved in zebraﬁsh
reward.184,189,191–194 For example, mutants heterozygous for a
non-sense mutation in the AChE (ache+/− ) gene184 display
reduced amphetamine-induced reward in a modiﬁed CPP
paradigm, demonstrating the conservation of cholinergic regula-
tion of reward pathways.
Although sensitivity to the rewarding effects of drugs is a
fundamental aspect of vulnerability to addiction, addiction itself is
characterized by the progression from occasional or transient to
habitual drug taking, compulsive drug seeking and a tendency to
relapse even after prolonged abstinence.195 Both drug-seeking
despite adverse consequences, and reinstatement of drug seeking
following extinction are commonly used to model these behaviors
in laboratory species.196 Recent studies demonstrate persistent
drug-seeking despite punishment197 and relapse198 in zebraﬁsh
chronically exposed to either nicotine or ethanol. Microarray
analysis in this model reveals shared changes in gene expression,
consistent with conservation of neuroadaptations and the
establishment of dependence in zebraﬁsh.197 Collectively, these
ﬁndings show that genetic and neural pathways are well con-
served between mammals and ﬁsh, and that ﬁsh employ similar
molecular adaptations following chronic drug exposure.199
In addition to classical screening techniques in adult ﬁsh to
identify strains with aberrant drug responsivity, more targeted
approaches help identify speciﬁc genes involved in drug sen-
sitivity. Fluorescently tagged GBT mutagenesis has been used to
examine molecular inﬂuences on a measure of nicotine addiction,
behavioral sensitization.116 This insertional method represents a
leap forward from classic mutagenesis, enabling both visual
identiﬁcation of carriers and rapid identiﬁcation of the disrupted
gene. In a screen of GBT mutant strains for nicotine behavioral
sensitization, 5-dpf larvae were exposed to nicotine acutely or 8 h
following previous administration of this drug. Acute exposure
caused an overt locomotor response, signiﬁcantly accentuated in
the larvae pre-treated with nicotine. GBT-mutagenized families
with diminished acute and sensitized responses to nicotine,
identiﬁed in this screen, included the bdav mutants with a
truncation in chaperonin-containing protein 8 (ccb8, linked to
nicotinic acetylcholine receptor), and the hbog zebraﬁsh with a
mutant ortholog of the GABA-B receptor (gabbr1.2).59,116 Further-
more, the behavioral phenotypes in these strains were reverted by
cre-mediated recombination, revealing speciﬁc loci in zebraﬁsh
that may lead to translational targets for the treatment of tobacco
addiction.116
Alcohol
Alcohol is the drug with the longest history of use and abuse in
human society. Although legally accepted and culturally tolerated,
it is a dangerous drug, and alcohol-related disorders present an
enormous burden for the patient and society.200 Alcohol is a
complex drug, affecting multiple mechanisms and behaviors in a
dose- and use-dependent manner. This complexity is one of the
reasons why effective therapies are still lacking, and alcohol-
related disorders remain a serious medical concern. In general,
ﬁndings from zebraﬁsh alcohol research can by evaluated by three
main criteria of a translationally acceptable model—face, con-
struct and predictive validity. Addressing face validity, recent
studies suggest that zebraﬁsh respond to alcohol in a manner
highly homologous to that of humans (Figure 2e).133 For example,
acute administration of alcohol makes ﬁsh agitated at intermedi-
ate doses, but lethargic at higher doses.201 Zebraﬁsh exhibit motor
impairment in response to high doses of acute alcohol (for
example, 1%), but show elevated aggression in response to
intermediate (for example, 0.25–0.50%) doses.133 Acute alcohol
also impairs zebraﬁsh response to social stimuli in a linear dose-
dependent manner (Figure 2e), a reaction that is strikingly similar
to that in humans.133,202 Chronic exposure to alcohol evokes
tolerance in zebraﬁsh, paralleling clinical ﬁndings.203 Withdrawal
from alcohol also leads to responses (for example, elevated motor
activity, anxiety, incoordination and reduced shoaling), phenoty-
pically similar in zebraﬁsh and humans (Figure 2e).203, 204 Likewise,
embryonic alcohol exposure in zebraﬁsh further parallels the
clinical effects of embryonic alcohol exposure, including the social
and learning impairment observed in fetal alcohol spectrum
disorders.10,205
Mounting evidence also suggests signiﬁcant construct validity
of zebraﬁsh alcohol models. For example, following acute or
chronic alcohol treatment, zebraﬁsh show similar neurochemical
alterations in the brain, compared with humans. Acute alcohol
induces a rapid increase in brain DA, which is blunted after chronic
alcohol exposure.203 Likewise, withdrawal from alcohol increases
brain DA levels,203 whereas chronic alcohol exposure alters the
expression of nearly 2000 genes in zebraﬁsh, many of which have
been implicated in human alcoholism.206
One of the greatest challenges for modeling the effects of
alcohol in zebraﬁsh is establishing predictive validity—the extent
to which drugs (with particular known effects on human CNS) act
in the same way in the zebraﬁsh system. While the model system
is expected to show efﬁcacy of human drugs in the predicted
manner, only a limited number of compounds expected to
mediate the effects of alcohol has been assessed in zebraﬁsh.
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However, zebraﬁsh have largely been shown to respond in a
predictable manner to such compounds, paralleling clinical effects
and suggesting a conservation of the main neurotransmitter
signaling pathways between zebraﬁsh and humans. Overall, while
future studies are needed to further assess their face, construct
and predictive validity as models of alcohol-related disorders,
zebraﬁsh already shows a signiﬁcant potential in this ﬁeld.
CURRENT CHALLENGES
The advantages and limitations of zebraﬁsh in biopsychiatry
research have recently been discussed in the literature.9–11,174
However, despite recent progress in zebraﬁsh neurobiology, many
important questions remain to be addressed. For example, the
logical step in the development of zebraﬁsh models with
translational relevance to human addiction is to apply systematic
screening of mutagenized families, to characterize genetic risk
factors associated with drug abuse. Humans with addiction and
other linked psychiatric disorders (for example, compulsive
gambling, obsessive compulsive disorder, Tourette’s syndrome
or ADHD) often display deﬁcits in general cognitive or executive
function207–210 (which becomes relevant to studying the mole-
cular basis of cognitive dysfunction linked to addiction). Emerging
as a key endophenotype for cocaine addiction,211,212 trait
impulsivity represents several behavioral constructs, including
inability/unwillingness to wait, choice of smaller but more
immediate (over larger, delayed) rewards, and motor impulsivity
(failure to inhibit a pre-potent response).213 In compulsive drug
use in rodents, animals with high levels of motor impulsivity
(assessed by premature responses on a test of sustained attention,
the 5-CSRTT (ﬁve-choice serial reaction time task)214) also show
compulsive cocaine seeking211 and increased relapse after
extinction training.215 This task has recently been adapted for
zebraﬁsh,216 resulting in a fully automated model,217 validated
pharmacologically by showing dose-dependent reductions in ﬁsh
impulsivity following atomoxetine,218 similar to rodents.219
Collectively, this provides the exciting prospect of using three-
generation screens (discussed above) or insertional transposon
technologies to study impulsivity, thus fostering the search for the
molecular basis of psychiatric disorders linked to impulsivity and
other reward-related traits.
Likewise, the ability to develop novel zebraﬁsh models of ADHD
is also interesting and translationally relevant. However, the
suitability of zebraﬁsh models (for example, mutants lacking
lphn3.1 function) as an ADHD-like model must be further
established by testing other behaviors, such as performance in
the 5-CSRTT.217 Although such a complex task will require a stable
lphn3.1 line to be established, this approach would be ideal to
reinforce the utility of lphn3.1 and other mutant ﬁsh as a tool to
study the neurobiology of ADHD.
Because the formation, position and function of neurotransmit-
ter signaling pathways sometimes differ between zebraﬁsh and
other vertebrates, comparative studies become important. For
example, as already mentioned, similar to other teleosts, zebraﬁsh
have undergone a partial genome duplication, and some genes
found in a single copy on the mammalian chromosome have two
copies in the zebraﬁsh chromosome.220 Such genetic redundancy
can make it more difﬁcult to analyze a disease gene’s function (for
example, if the effect of a mutated gene is masked by the
unaltered ‘sister’ gene). While the function of some receptors and
transporters is conserved across species,17,65 the increased
spectrum of neurotransmitter signaling-related molecules in
zebraﬁsh (vs mammals) suggests that their functional properties
merit further scrutiny in genetic and pharmacological studies.
However, this redundancy can also present an opportunity (for
example, permitting the analysis of the effects of genes whose
null mutations lead to developmental lethality if in a single copy, a
common problem in mouse knockout studies).
From an evolutionary perspective, there are also important
physiological differences between mammals and zebraﬁsh. For
example, ﬁsh are poikiloterms and mammals are homeothermic
animals, and substantial differences exist in metabolism and organ
systems between species.221 Likewise, there are also well-known
differences in brain development between ﬁsh and mammals,
which will be only brieﬂy mentioned here. For instance, instead of
the laminar cortex, telencephalic nuclei in teleost ﬁshes have
evolved as the pallium, containing similar but simpler neural
circuits, compared with the mammalian cortex, which also has
some additional circuits222 (note, however, recent data showing
that emotions and motivated behavior in zebraﬁsh converge on
an amygdala-like structure, similar to their mammalian counter-
parts111). Another interesting example is the habenula—a key
relay nucleus connecting the forebrain with the brainstem and
modulating monoaminergic mechanisms of behavior and cogni-
tion.223 Although the development of its circuits appears to be
conserved phylogenetically, some species differences in habenular
asymmetry exist between ﬁsh and mammals223 (note, however,
mounting evidence showing that the zebraﬁsh habenula, like in
humans,224 has an important role in the regulation of affective
behavior and aversive memories152,225–227). While not within the
scope of this review, such physiological and neurobiological
differences between species must be considered critically when
translating zebraﬁsh responses into human disorders.221 Together
with some genetic differences between species12 and poorly
characterized protein function differences (stemming from
divergent evolution), this represents a serious current challenge
for zebraﬁsh molecular psychiatry.
Finally, perhaps the biggest challenge in multidisciplinary
zebraﬁsh studies is the behavioral models and tools.9,10 Despite
a rapidly growing research in this ﬁeld, the zebraﬁsh is still a new
model in behavioral neuroscience.11 Will zebraﬁsh analyses keep
pace with the rapid advancement of molecular and neurobiolo-
gical tools developed for this species? While the answer to this
question is unclear, recent evidence offers grounds for optimism.
For example, the rapidly increasing computer processing power,
coupled with constantly improving 2D and 3D video-recording
and imaging tools, generates behavioral data with ever increasing
quality, precision and spatiotemporal resolution. Simultaneous
video-tracking of a large number of ﬁsh (either swimming in
separate compartments; Figure 2b or moving together in a group/
shoal)10,160 now became a reality. As behavioral quantiﬁcation
becomes more precise, so does the delivery of stimuli that induce
the behavioral responses. Because both stimulus delivery and
behavioral response quantiﬁcation are now increasingly compu-
terized and standardized, the behavioral paradigms in zebraﬁsh
become more automated and scalable. Thus, running such
multiple tasks in parallel makes even slow learning protocols high-
throughput and efﬁcient. Enhancing high-throughput screening
of mutants and drugs that affect complex behavioral responses
such as phenomics-based approaches in zebraﬁsh foster further
experimental modeling of human brain disorders.
CONCLUSION
Uncovering the molecular processes that underlie the formation
of neural circuits and their activity to control the behavior is key to
the understanding and treatment of psychiatric diseases.6,7
Recognizing the importance of zebraﬁsh to molecular psychiatry
is the critical step in our continued use of this model organism
to study neurobiological mechanisms of human brain disorders.
In addition to the growing availability of genetic and pharmaco-
logical assays and probes in zebraﬁsh, there is also an urgent
need for new behavioral assays and imaging neural pathways
and circuits implicated in various pathological states in this
species.228,229
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The availability of genetic, electrophysiological and optogenetic
tools, as well as multiple mutant and transgenic strains, physio-
logical biomarkers and robust protocols to measure behavior,
collectively supports zebraﬁsh potential for modeling psychiatric
disorders. As both larval and adult zebraﬁsh are now rapidly
becoming key model organisms in neuroscience research, they
represent a useful novel species for translational molecular
psychiatry and CNS drug discovery.
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